Modelling the impact of fexinidazole use on human African trypanosomiasis transmission in the Democratic Republic of Congo
View ORCID ProfileAatreyee M. Das, View ORCID ProfileNakul Chitnis, View ORCID ProfileChristian Burri, View ORCID ProfileDaniel H. Paris, Swati Patel, Simon E.F. Spencer, Erick M. Miaka, View ORCID ProfileM. Soledad Castaño
doi: https://doi.org/10.1101/2021.06.09.21258601
Aatreyee M. Das
1Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
2University of Basel, Basel, Switzerland
Nakul Chitnis
1Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
2University of Basel, Basel, Switzerland
Christian Burri
1Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
2University of Basel, Basel, Switzerland
Daniel H. Paris
1Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
2University of Basel, Basel, Switzerland
Swati Patel
3Department of Statistics, University of Warwick, Coventry, CV4 7AL, UK
Simon E.F. Spencer
3Department of Statistics, University of Warwick, Coventry, CV4 7AL, UK
Erick M. Miaka
4Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, the Democratic Republic of the Congo
M. Soledad Castaño
1Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
2University of Basel, Basel, Switzerland
Data Availability
The data underlying the results presented in the study are available upon request, to researchers who meet the required criteria, from the World Health Organization HAT Atlas (contact via Dr. Jose Ramon Franco Minguell - francoj{at}who.int).
Posted June 12, 2021.
Modelling the impact of fexinidazole use on human African trypanosomiasis transmission in the Democratic Republic of Congo
Aatreyee M. Das, Nakul Chitnis, Christian Burri, Daniel H. Paris, Swati Patel, Simon E.F. Spencer, Erick M. Miaka, M. Soledad Castaño
medRxiv 2021.06.09.21258601; doi: https://doi.org/10.1101/2021.06.09.21258601
Modelling the impact of fexinidazole use on human African trypanosomiasis transmission in the Democratic Republic of Congo
Aatreyee M. Das, Nakul Chitnis, Christian Burri, Daniel H. Paris, Swati Patel, Simon E.F. Spencer, Erick M. Miaka, M. Soledad Castaño
medRxiv 2021.06.09.21258601; doi: https://doi.org/10.1101/2021.06.09.21258601
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12766)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4600)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (926)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4377)
- Nursing (237)
- Nutrition (640)
- Oncology (2279)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1534)
- Respiratory Medicine (916)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)